Top Markets
Coin of the day
Chembio Diagnostics, Inc. Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc.

CEMI
Rang in Aktien #33406
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in... Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections. These diagnostic tools are sold under well-known brand names including STAT-PAK, SURE CHECK, STAT VIEW, and DPP. Chembio distributes its products directly and through various partners to a diverse global customer base. This clientele includes medical laboratories, hospitals, government and public health agencies, non-governmental organizations (NGOs), medical professionals, and retail outlets across the United States and worldwide. The company engages in strategic partnerships with prominent organizations such as the Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics. Additionally, Chembio collaborates with several key U.S. government entities, including the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture (USDA). Founded in 1985, Chembio Diagnostics, Inc. has its headquarters located in Hauppauge, New York.
Aktienkurs
$0.455
Zuletzt synchronisiert: 2023-04-27
Marktkapitalisierung
$7.70M
Veränderung (1 Tag)
0.22%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Chembio Diagnostics, Inc. (CEMI)

Kategorie

Kursverlauf für Chembio Diagnostics, Inc. (CEMI)
Höchster Schlusskurs: $0.45 am 2023-04-01

Niedrigster Schlusskurs: $169.14 am 2000-10-01
Kursverlauf der Aktie von Chembio Diagnostics, Inc. von 2000 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 67.72%
2022 -83.77%
2021 -71.32%
2020 28.79%
2019 -23.47%
2018 -22.11%
2017 10.94%
2016 30.05%
2015 25.31%
2014 22.82%
2013 -26.77%
2012 41.16%
2011 -3.42%
2010 49.48%
2009 128.56%
2008 -65.47%
2007 -52.25%
2006 88.65%
2005 -38.83%
2004 7.89%
2003 195.45%
2002 -98.22%
2001 -66.33%
2000 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$588.21 20.29%
US
$202.45 -4.02%
US
$24.18 77.60%
CN
$309.93 90.12%
US
$551.60 -15.25%
US